Skip to main content
VCbacked
Log inGet Started

Cascade Biocatalysts

Denver, United States

Cascade Biocatalysts creates productive enzymes for economical biomanufacturing of sustainable chemicals.

$5.4M raised
Aug 2025
Venture - Series Unknown
BiotechnologyChemicalManufacturing

Top Investors

Spacecadet VenturesBoost VCRange VenturesAmplify.LAThird Derivative

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cascade Biocatalysts

How much funding has Cascade Biocatalysts raised?
Cascade Biocatalysts has raised $5.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2025.
Who are Cascade Biocatalysts's investors?
Cascade Biocatalysts's investors include Spacecadet Ventures, Boost VC, Range Ventures, Amplify.LA, Third Derivative.
Where is Cascade Biocatalysts headquartered?
Cascade Biocatalysts is headquartered in Denver, United States.
What does Cascade Biocatalysts do?
Cascade Biocatalysts creates productive enzymes for economical biomanufacturing of sustainable chemicals.
What stage is Cascade Biocatalysts at?
Cascade Biocatalysts is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Cascade Biocatalysts — Funding & Investors." VCBacked, August 25, 2025, https://www.vcbacked.co/company/cascade-biocatalysts. Accessed June 7, 2026.
APA
VCBacked. (2025). Cascade Biocatalysts — Funding & Investors. Retrieved June 7, 2026, from https://www.vcbacked.co/company/cascade-biocatalysts
Wikipedia (cite web)
{{cite web |title=Cascade Biocatalysts — Funding & Investors |url=https://www.vcbacked.co/company/cascade-biocatalysts |website=VCBacked |access-date=June 7, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong